Lamivudine Unknown Status Phase 2 Trials for reactivation of hepatitis B virus infection / Non-Hodgkin's Lymphoma (NHL) Prevention

IndicationsStatusPurposePhase
Unknown StatusPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT01914744Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Reactivation in NHL